As of 2025-11-03, the EV/EBITDA ratio of Pulmonx Corp (LUNG) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LUNG's latest enterprise value is 27.18 mil USD. LUNG's TTM EBITDA according to its financial statements is -55.44 mil USD. Dividing these 2 quantities gives us the above LUNG EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.8x | 13.7x |
| Forward P/E multiples | 9.0x - 14.1x | 10.3x |
| Fair Price | (17.46) - (22.49) | (19.38) |
| Upside | -973.0% - -1224.6% | -1068.8% |
| Date | EV/EBITDA |
| 2025-10-31 | -0.49 |
| 2025-10-30 | -0.35 |
| 2025-10-29 | -0.44 |
| 2025-10-28 | -0.48 |
| 2025-10-27 | -0.23 |
| 2025-10-24 | -0.28 |
| 2025-10-23 | -0.25 |
| 2025-10-22 | -0.26 |
| 2025-10-21 | -0.26 |
| 2025-10-20 | -0.30 |
| 2025-10-17 | -0.21 |
| 2025-10-16 | -0.24 |
| 2025-10-15 | -0.26 |
| 2025-10-14 | -0.24 |
| 2025-10-13 | -0.25 |
| 2025-10-10 | -0.24 |
| 2025-10-09 | -0.33 |
| 2025-10-08 | -0.36 |
| 2025-10-07 | -0.33 |
| 2025-10-06 | -0.34 |
| 2025-10-03 | -0.40 |
| 2025-10-02 | -0.31 |
| 2025-10-01 | -0.29 |
| 2025-09-30 | -0.27 |
| 2025-09-29 | -0.29 |
| 2025-09-26 | -0.34 |
| 2025-09-25 | -0.32 |
| 2025-09-24 | -0.36 |
| 2025-09-23 | -0.39 |
| 2025-09-22 | -0.40 |
| 2025-09-19 | -0.31 |
| 2025-09-18 | -0.26 |
| 2025-09-17 | -0.23 |
| 2025-09-16 | -0.24 |
| 2025-09-15 | -0.25 |
| 2025-09-12 | -0.32 |
| 2025-09-11 | -0.31 |
| 2025-09-10 | -0.26 |
| 2025-09-09 | -0.31 |
| 2025-09-08 | -0.32 |
| 2025-09-05 | -0.34 |
| 2025-09-04 | -0.34 |
| 2025-09-03 | -0.29 |
| 2025-09-02 | -0.33 |
| 2025-08-29 | -0.32 |
| 2025-08-28 | -0.35 |
| 2025-08-27 | -0.41 |
| 2025-08-26 | -0.36 |
| 2025-08-25 | -0.30 |
| 2025-08-22 | -0.31 |